Chronic Pancreatitis Epiomic Epidemiology Report 2018-2028

DUBLIN, May 11, 2018 /PRNewswire/ --

The "Epiomic Epidemiology Series: Chronic Pancreatitis Forecast In 23 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Chronic pancreatitis (CP) is a persistent low-level inflammation of the pancreas involving progressive inflammatory and fibrotic changes in the exocrine parts of the organ. As a result of constant inflammation, scarring and fibrosis of the pancreatic ducts occur, leading to permanent structural damage and impairment the organ's secretory functions. Eventually, both endocrine and exocrine functions become impaired. CP has a strongly debilitating effect on patients, leading to malnutrition, weight loss and pancreatogenic diabetes, and causing persistent abdominal pain that is difficult to alleviate.

This report provides the current prevalent population for chronic pancreatitis across 23 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Finland, Denmark, Austria, Switzerland, Czech Republic, Hungary, Turkey, Japan, China, South Korea, India, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Chronic pancreatitis patients grouped by aetiology, as well as the main comorbidities of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of chronic pancreatitis include:

• Alcoholism
• Malabsorption with weight loss
• Type 3c diabetes mellitus
• Osteopenia/osteoporosis
• Coeliac disease
• Cystic fibrosis
• Gallstones
• Pancreatic cancer
• Depression
  

Key Topics Covered:

1. List Of Tables And Figures

2. Introduction

3. Cause Of The Disease

4. Risk Factors & Prevention

5. Diagnosis Of The Disease

6. Variation By Geography/Ethnicity

7. Disease Prognosis & Clinical Course

8. Key Comorbid Conditions / Features Associated With The Disease

9. Methodology For Quantification Of Patient Numbers

10. Top-Line Prevalence For Chronic Pancreatitis

11. Features Of Chronic Pancreatitis Patients

12. Comorbidities Of Chronic Pancreatitis Patients

13. Abbreviations Used In The Report

14. Reports & Publications

15. Online Epidemiology Databases

16. Online Pharmaceutical Pricing Database

17. References

18. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/h649mb/chronic?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/chronic-pancreatitis-epiomic-epidemiology-report-2018-2028-300647091.html

SOURCE Research and Markets